IS
Ian Shakil
Chief Strategy OfficerDirector

Ian Shakil insider trades: Augmedix (AUGX) stock sales

Chief Strategy Officer, Augmedix Last trade May 15, 2024 18 Form 4 filings
$0
Sold, last 12 months
0 sales
$0
Bought, last 12 months
0 buys
8
Open-market trades
since 2024
2
Companies
last trade 2024

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Ian reports to the SEC

AUGX
AUGXAugmedix
Chief Strategy Officer · last filing Oct 4, 2024
-$1.8M
NONEAugmedix
Chief Strategy Officer · last filing Jan 21, 2021
No market trades

Open-market buys and sales

8 trades reported on SEC Form 4, newest first

DateStockTypeValue
May 15, 2024AUGX↓ Sell$2K
Apr 15, 2024AUGX↓ Sell$2K
Apr 12, 2024AUGX↓ Sell$75K
Apr 11, 2024AUGX↓ Sell$369K
Apr 8, 2024AUGX↓ Sell$357K
Apr 4, 2024AUGX↓ Sell$454K
Apr 2, 2024AUGX↓ Sell$380K
Mar 28, 2024AUGX↓ Sell$130K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

About Ian Shakil's insider trades

Ian Shakil is Chief Strategy Officer at Augmedix (AUGX). Since Mar 28, 2024, Ian has reported no open-market purchases and 8 sales worth $1.8M on SEC Form 4. There have been no open-market trades in the last 12 months.

Their filings also include option exercises (8 filings), grants and awards (8 filings), shares withheld for taxes (2 filings), shares returned to the company (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every AUGX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.